BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3098654)

  • 21. Platelet and aorta arachidonic and eicosapentaenoic acid levels and in vitro eicosanoid production in rats fed high-fat diets.
    Sanigorski AJ; Sinclair AJ; Hamazaki T
    Lipids; 1996 Jul; 31(7):729-35. PubMed ID: 8827696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of dietary fatty acids on the accumulation of arachidonic acid and its metabolic conversion through the cyclooxygenase and lipoxygenase in platelets and vascular tissue.
    Galli C; Agradi E; Petroni A; Tremoli E
    Lipids; 1981 Mar; 16(3):165-72. PubMed ID: 6783805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation.
    Koo KL; Ammit AJ; Tran VH; Duke CC; Roufogalis BD
    Thromb Res; 2001 Sep; 103(5):387-97. PubMed ID: 11553371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition in vitro of platelet aggregation and arachidonic acid metabolism by flavone.
    Mower RL; Landolfi R; Steiner M
    Biochem Pharmacol; 1984 Feb; 33(3):357-63. PubMed ID: 6322801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-activating factor-induced vasoconstriction in rat isolated, perfused hearts: contribution of cyclo-oxygenase and lipoxygenase arachidonic acid metabolites.
    Stewart AG; Piper PJ
    Pharmacol Res Commun; 1986 Aug; 18 Suppl():163-72. PubMed ID: 3095850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.
    Schrör K; Moncada S; Ubatuba FB; Vane JR
    Eur J Pharmacol; 1978 Jan; 47(1):103-14. PubMed ID: 338313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of catechol derivatives on arachidonic acid-induced aggregation of rabbit platelets.
    Kitagawa S; Fujisawa H; Baba S; Kametani F
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):1062-4. PubMed ID: 1909935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.
    Gryglewski RJ; Bunting S; Moncada S; Flower RJ; Vane JR
    Prostaglandins; 1976 Nov; 12(5):685-713. PubMed ID: 824685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of green tea catechin on arachidonic acid cascade in chronic cadmium-poisoned rats.
    Choi JH; Chang HW; Rhee SJ
    Asia Pac J Clin Nutr; 2002; 11(4):292-7. PubMed ID: 12495261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism.
    Srivastava KC
    Biomed Biochim Acta; 1984; 43(8-9):S335-46. PubMed ID: 6440548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-thrombotic and anti-inflammatory activities of protopine.
    Saeed SA; Gilani AH; Majoo RU; Shah BH
    Pharmacol Res; 1997 Jul; 36(1):1-7. PubMed ID: 9368908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression by beta-lactam antibiotics of thromboxane A2 generation and arachidonic acid release in rabbit platelets in vitro.
    Mihara S; Fujimoto M; Okabayashi T
    Thromb Res; 1986 Nov; 44(3):265-75. PubMed ID: 3798399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
    Mehta J; Mehta P; Hay D
    Prostaglandins; 1982 Dec; 24(6):751-61. PubMed ID: 6820166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural requirements for preventing the aspirin- and the arachidonate-induced inactivation of platelet cyclo-oxygenase: additional evidence for distinct enzymatic sites.
    Rotilio D; Joseph D; Hatmi M; Vargaftig BB
    Eur J Pharmacol; 1984 Jan; 97(3-4):197-208. PubMed ID: 6423393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelium-dependent inhibition of platelet aggregation.
    Azuma H; Ishikawa M; Sekizaki S
    Br J Pharmacol; 1986 Jun; 88(2):411-5. PubMed ID: 3089351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
    Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M
    Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Release of labile cyclo-oxygenase products of arachidonic acid from kidney by endotoxin.
    Ozsan K; Içöz V; Türker RK
    Experientia; 1984 Aug; 40(8):815-6. PubMed ID: 6432573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JJK694, a synthesized obovatol derivative, inhibits platelet activation by suppressing cyclooxygenase and lipoxygenase activities.
    Yu JY; Lee JJ; Jung JK; Min YK; Kim TJ; Ma JY; Lee MY; Yun YP
    Biosci Biotechnol Biochem; 2012; 76(11):2038-43. PubMed ID: 23132562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M
    Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of platelet thromboxane generation by suloctidil in man.
    Bucchi F; Cerletti C; de Gaetano G
    Haemostasis; 1986; 16(5):362-8. PubMed ID: 3023210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.